Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Project Grant

Université de Montréal

$928,869.00

Characterization of the Cdc37/Hsp90 complex as a regulator of the Notch ligands

FY 2015-16

Summary
Communication between cells are performed through so-called cell signalling pathway, which are important to control several developmental and maintenance aspects of animals. Dysregulation of cell signalling can be problematic and lead to diseases, including cancers. One of the signalling pathway involved in various cancer, including some leukemias, is the Notch signalling pathway. By using an original approach, we have identified new regulators, including a potential therapeutic target, which can be blocked by existing drugs. Here we will further investigate the possibility to use these drugs and block particular Notch mediated cancers, such as T-cell Lymphoblastic Leukemia (T-ALL).
Program
Project Grant
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
347248
Name
Emery Gregory
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Project Grant Competition
Projecttitle
Characterization of the Cdc37/Hsp90 complex as a regulator of the Notch ligands
Programtype2
Operating Grants
Orgnameinp2
Université de Montréal
Cihramount2
$928,869
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Cancer; Cdc37; Cell Signalling; Chaperone; Delta; Leukemia; Notch Signalling; T-All
Abstract
Communication between cells are performed through so-called cell signalling pathway, which are important to control several developmental and maintenance aspects of animals. Dysregulation of cell signalling can be problematic and lead to diseases, including cancers. One of the signalling pathway involved in various cancer, including some leukemias, is the Notch signalling pathway. By using an original approach, we have identified new regulators, including a potential therapeutic target, which can be blocked by existing drugs. Here we will further investigate the possibility to use these drugs and block particular Notch mediated cancers, such as T-cell Lymphoblastic Leukemia (T-ALL).
Competitiondate
201603
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Emery, Gregory
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $928,869~ $0~
Université de Montréal - $928,869 Grant (2015-16) | Canada Spends